Bristol-Myers Squibb Company
Modified self-immolating moieties for use in prodrugs and conjugates and methods of using and making

Last updated:

Abstract:

Compounds represented by formula (I) ##STR00001## can be used to make antibody-drug conjugates. The conjugates so made are stable in both human and mouse serum, enabling the performance of pre-clinical studies using a mouse model.

Status:
Grant
Type:

Utility

Filling date:

29 May 2019

Issue date:

26 Jan 2021